Boothbay Fund Management’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Other funds holding UTHR
Boothbay Fund Management's UTHR Position: Q3 2026 in Review
Boothbay Fund Management sold out of United Therapeutics (UTHR) in Q3 2026, closing a stake of 782 shares — an estimated $424K sold.
Boothbay Fund Management first reported a position in UTHR in Q1 2017 and held it in 9 quarters. The position peaked at $1.58M in Q1 2021. 846 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.
- Boothbay Fund Management reported no remaining United Therapeutics position as of Q3 2026 after selling out during the quarter.
- Boothbay Fund Management sold 782 United Therapeutics shares in Q3 2026, an estimated $424K.
- Boothbay Fund Management first reported a position in United Therapeutics in Q1 2017 and held it in 9 quarters.
- Boothbay Fund Management's United Therapeutics position peaked at $1.58M in Q1 2021.
- 846 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.
Based on Boothbay Fund Management's 13F filing for Q3 2026, filed 16 Nov 2026.